Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 31847 | 95764;95765;95766 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
N2AB | 30206 | 90841;90842;90843 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
N2A | 29279 | 88060;88061;88062 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
N2B | 22782 | 68569;68570;68571 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
Novex-1 | 22907 | 68944;68945;68946 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
Novex-2 | 22974 | 69145;69146;69147 | chr2:178545571;178545570;178545569 | chr2:179410298;179410297;179410296 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R/C | rs774814532 | -1.7 | 1.0 | N | 0.919 | 0.535 | 0.437850553699 | gnomAD-2.1.1 | 2.41E-05 | None | None | None | None | N | None | 0 | 2.9E-05 | None | 0 | 2.22568E-04 | None | 0 | None | 0 | 8.87E-06 | 0 |
R/C | rs774814532 | -1.7 | 1.0 | N | 0.919 | 0.535 | 0.437850553699 | gnomAD-3.1.2 | 6.57E-06 | None | None | None | None | N | None | 0 | 0 | 0 | 0 | 1.92827E-04 | None | 0 | 0 | 0 | 0 | 0 |
R/C | rs774814532 | -1.7 | 1.0 | N | 0.919 | 0.535 | 0.437850553699 | gnomAD-4.0.0 | 1.36341E-05 | None | None | None | None | N | None | 0 | 1.66706E-05 | None | 0 | 1.78245E-04 | None | 0 | 3.29056E-04 | 9.3242E-06 | 0 | 0 |
R/H | rs771179752 | -2.762 | 1.0 | N | 0.765 | 0.644 | None | gnomAD-2.1.1 | 4.02E-05 | None | None | None | None | N | None | 0 | 0 | None | 0 | 1.11272E-04 | None | 3.27E-05 | None | 1.39237E-04 | 3.55E-05 | 0 |
R/H | rs771179752 | -2.762 | 1.0 | N | 0.765 | 0.644 | None | gnomAD-3.1.2 | 1.31E-05 | None | None | None | None | N | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 2.94E-05 | 0 | 0 |
R/H | rs771179752 | -2.762 | 1.0 | N | 0.765 | 0.644 | None | gnomAD-4.0.0 | 4.46199E-05 | None | None | None | None | N | None | 0 | 1.66694E-05 | None | 0 | 3.11929E-04 | None | 7.80933E-05 | 6.58111E-04 | 3.8992E-05 | 2.19587E-05 | 0 |
R/P | rs771179752 | None | 1.0 | D | 0.873 | 0.749 | 0.565354849907 | Rees (2021) | None | MmD | comp het with R5430* | None | None | N | Genetic analysis of TTN in 30 CM patients; comp het with truncating; Domain unfolded in vitro; cannot be re-folded | None | None | None | None | None | None | None | None | None | None | None |
R/P | rs771179752 | None | 1.0 | D | 0.873 | 0.749 | 0.565354849907 | gnomAD-4.0.0 | 6.84237E-07 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 8.99523E-07 | 0 | 0 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R/A | 0.9687 | likely_pathogenic | 0.9711 | pathogenic | -2.169 | Highly Destabilizing | 0.999 | D | 0.509 | neutral | None | None | None | None | N |
R/C | 0.5596 | ambiguous | 0.552 | ambiguous | -1.946 | Destabilizing | 1.0 | D | 0.919 | deleterious | N | 0.489476721 | None | None | N |
R/D | 0.9972 | likely_pathogenic | 0.9976 | pathogenic | -0.81 | Destabilizing | 1.0 | D | 0.845 | deleterious | None | None | None | None | N |
R/E | 0.9576 | likely_pathogenic | 0.964 | pathogenic | -0.599 | Destabilizing | 0.999 | D | 0.507 | neutral | None | None | None | None | N |
R/F | 0.9611 | likely_pathogenic | 0.9624 | pathogenic | -1.465 | Destabilizing | 1.0 | D | 0.913 | deleterious | None | None | None | None | N |
R/G | 0.9595 | likely_pathogenic | 0.9613 | pathogenic | -2.514 | Highly Destabilizing | 1.0 | D | 0.715 | prob.delet. | N | 0.507985823 | None | None | N |
R/H | 0.3992 | ambiguous | 0.4505 | ambiguous | -2.204 | Highly Destabilizing | 1.0 | D | 0.765 | deleterious | N | 0.508492802 | None | None | N |
R/I | 0.922 | likely_pathogenic | 0.9183 | pathogenic | -1.166 | Destabilizing | 1.0 | D | 0.911 | deleterious | None | None | None | None | N |
R/K | 0.2456 | likely_benign | 0.2398 | benign | -1.291 | Destabilizing | 0.998 | D | 0.492 | neutral | None | None | None | None | N |
R/L | 0.8152 | likely_pathogenic | 0.8153 | pathogenic | -1.166 | Destabilizing | 1.0 | D | 0.715 | prob.delet. | N | 0.50903578 | None | None | N |
R/M | 0.848 | likely_pathogenic | 0.846 | pathogenic | -1.553 | Destabilizing | 1.0 | D | 0.843 | deleterious | None | None | None | None | N |
R/N | 0.9861 | likely_pathogenic | 0.9894 | pathogenic | -1.191 | Destabilizing | 1.0 | D | 0.688 | prob.neutral | None | None | None | None | N |
R/P | 0.999 | likely_pathogenic | 0.9991 | pathogenic | -1.49 | Destabilizing | 1.0 | D | 0.873 | deleterious | D | 0.532926933 | None | None | N |
R/Q | 0.3785 | ambiguous | 0.386 | ambiguous | -1.187 | Destabilizing | 1.0 | D | 0.675 | neutral | None | None | None | None | N |
R/S | 0.9901 | likely_pathogenic | 0.9908 | pathogenic | -2.247 | Highly Destabilizing | 1.0 | D | 0.707 | prob.neutral | N | 0.492600138 | None | None | N |
R/T | 0.9704 | likely_pathogenic | 0.9714 | pathogenic | -1.82 | Destabilizing | 1.0 | D | 0.71 | prob.delet. | None | None | None | None | N |
R/V | 0.9371 | likely_pathogenic | 0.9343 | pathogenic | -1.49 | Destabilizing | 1.0 | D | 0.881 | deleterious | None | None | None | None | N |
R/W | 0.7096 | likely_pathogenic | 0.6883 | pathogenic | -0.863 | Destabilizing | 1.0 | D | 0.901 | deleterious | None | None | None | None | N |
R/Y | 0.8667 | likely_pathogenic | 0.8717 | pathogenic | -0.758 | Destabilizing | 1.0 | D | 0.909 | deleterious | None | None | None | None | N |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.